Literature DB >> 20119835

C-kit+ CD45- cells found in the adult human heart represent a population of endothelial progenitor cells.

Joakim Sandstedt1, Marianne Jonsson, Anders Lindahl, Anders Jeppsson, Julia Asp.   

Abstract

Although numerous reports support the existence of stem cells in the adult heart, few studies have been conducted using human cardiac tissue. Therefore, cells from human cardiac atrial biopsies were analyzed regarding progenitor properties. Expression of stem cell markers was analyzed using fluorescence-activated cell sorting. This identified a small population of C-kit+ cells, which could be further subdivided based on expression of CD45. The C-kit+ CD45+ population was determined to be of mast cell identity, while the C-kit+ CD45- population expressed mRNA of the endothelial lineage. Since the number of cells obtainable from biopsies was limited, a comparison between directly isolated and monolayer and explant cultured cells, respectively, was carried out. While both cultures retained a small population of mast cells, only monolayer culture produced a stable and relatively high percentage of C-kit+ CD45- cells. This population was found to co-express endothelial progenitor cell markers such as CD31, CD34, CXCR4, and FLK-1. The mRNA expression profile was similar to the one from directly isolated cells. When sorted cells were cultured in endothelial differentiation medium, the C-kit+ CD45- population retained its expression of endothelial markers to a large extent, but downregulated progenitor markers, indicating further differentiation into endothelial cells. We have confirmed that the human cardiac atrium contains a small C-kit+ CD45- population expressing markers commonly found on endothelial progenitor cells. The existence of an endothelial progenitor population within the heart might have future implications for developing methods of inducing neovascularization after myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20119835     DOI: 10.1007/s00395-010-0088-1

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  32 in total

Review 1.  Stem cell-based therapies in ischemic heart diseases: a focus on aspects of microcirculation and inflammation.

Authors:  Junxi Wu; Jun Li; Nannan Zhang; Cuihua Zhang
Journal:  Basic Res Cardiol       Date:  2011-03-23       Impact factor: 17.165

2.  Physical exercise affects slow cycling cells in the rat heart and reveals a new potential niche area in the atrioventricular junction.

Authors:  Kristina Vukusic; Julia Asp; Helena Barreto Henriksson; Helena Brisby; Anders Lindahl; Joakim Sandstedt
Journal:  J Mol Histol       Date:  2015-06-06       Impact factor: 2.611

Review 3.  Molecular basis of functional myogenic specification of Bona Fide multipotent adult cardiac stem cells.

Authors:  Eleonora Cianflone; Iolanda Aquila; Mariangela Scalise; Pina Marotta; Michele Torella; Bernardo Nadal-Ginard; Daniele Torella
Journal:  Cell Cycle       Date:  2018-06-25       Impact factor: 4.534

Review 4.  Cardiac progenitor/stem cells on myocardial infarction or ischemic heart disease: what we have known from current research.

Authors:  Hao Zhang; Hong Wang; Na Li; Chang-En Duan; Yue-Jin Yang
Journal:  Heart Fail Rev       Date:  2014-03       Impact factor: 4.214

5.  Human endothelial progenitor cells isolated from COPD patients are dysfunctional.

Authors:  Xiaoran Liu; Canmao Xie
Journal:  Mol Cell Biochem       Date:  2011-12-04       Impact factor: 3.396

Review 6.  Heart regeneration.

Authors:  Michael A Laflamme; Charles E Murry
Journal:  Nature       Date:  2011-05-19       Impact factor: 49.962

Review 7.  Cardiac-derived stem cell-based therapy for heart failure: progress and clinical applications.

Authors:  Yaoliang L Tang; Yingjie J Wang; Lijuan J Chen; Yaohua H Pan; Lan Zhang; Neal L Weintraub
Journal:  Exp Biol Med (Maywood)       Date:  2013-03

8.  Identification of the hemogenic endothelial progenitor and its direct precursor in human pluripotent stem cell differentiation cultures.

Authors:  Kyung-Dal Choi; Maxim A Vodyanik; Padma Priya Togarrati; Kran Suknuntha; Akhilesh Kumar; Fnu Samarjeet; Mitchell D Probasco; Shulan Tian; Ron Stewart; James A Thomson; Igor I Slukvin
Journal:  Cell Rep       Date:  2012-09-13       Impact factor: 9.423

9.  Increased potency of cardiac stem cells compared with bone marrow mesenchymal stem cells in cardiac repair.

Authors:  Behzad N Oskouei; Guillaume Lamirault; Chacko Joseph; Adriana V Treuer; Stephanie Landa; Jose Da Silva; Konstantinos Hatzistergos; Marc Dauer; Wayne Balkan; Ian McNiece; Joshua M Hare
Journal:  Stem Cells Transl Med       Date:  2012-02-07       Impact factor: 6.940

10.  Heart cells with regenerative potential from pediatric patients with end stage heart failure: a translatable method to enrich and propagate.

Authors:  Ann Steele; Robert J Boucek; Jeffrey Phillip Jacobs; Peter Steele; Alfred Asante-Korang; Wilfredo Chamizo; Jasmine Steele; Paul J Chai; James A Quintessenza
Journal:  Stem Cells Int       Date:  2012-08-14       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.